{ "company_number": "NI071217", "name": "Belfast Drug Ltd", "url": "/company/NI071217", "status": "active", "is_active": true, "company_type": "ltd", "incorporated_on": "2008-12-03", "dissolved_on": null, "sic_codes": [ { "code": "46460", "description": "Wholesale of pharmaceutical goods", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/46460" } ], "registered_address": { "id": 998434, "url": "/address/998434", "line1": "14C ADELAIDE PARK", "line2": "", "post_town": "BELFAST", "county": "", "country": "NORTHERN IRELAND", "postcode": "BT9 6FX" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/NI071217", "previous_names": [ { "name": "Riverview Trading Limited", "ceased_on": "2009-01-09" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-09-30", "last_made_up": "2024-12-31", "category": "MICRO ENTITY", "filings": [ { "url": "/company/NI071217/accounts/2025-12-31", "pdf_url": "/company/NI071217/accounts/2025-12-31.pdf", "made_up_date": "2025-12-31", "period_start": "2025-12-31", "period_end": "2025-12-31", "entity_name": "Belfast Drug Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "90.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "90.00", "total_assets_less_current_liabilities": "90.00", "net_assets_liabilities": "-203086.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-203086.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-09-29.zip" }, { "url": "/company/NI071217/accounts/2024-12-31", "pdf_url": "/company/NI071217/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-12-31", "period_end": "2024-12-31", "entity_name": "Belfast Drug Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "63.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "63.00", "total_assets_less_current_liabilities": "63.00", "net_assets_liabilities": "-202915.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-202915.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/NI071217/accounts/2023-12-31", "pdf_url": "/company/NI071217/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-12-31", "period_end": "2023-12-31", "entity_name": "Belfast Drug Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "32.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "32.00", "total_assets_less_current_liabilities": "32.00", "net_assets_liabilities": "-202743.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-202743.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2024.zip" }, { "url": "/company/NI071217/accounts/2022-12-31", "pdf_url": "/company/NI071217/accounts/2022-12-31.pdf", "made_up_date": "2022-12-31", "period_start": "2022-12-31", "period_end": "2022-12-31", "entity_name": "Belfast Drug Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "17.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "17.00", "total_assets_less_current_liabilities": "17.00", "net_assets_liabilities": "-202574.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-202574.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2023.zip" }, { "url": "/company/NI071217/accounts/2021-12-31", "pdf_url": "/company/NI071217/accounts/2021-12-31.pdf", "made_up_date": "2021-12-31", "period_start": "2021-12-31", "period_end": "2021-12-31", "entity_name": "Belfast Drug Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "16.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "16.00", "total_assets_less_current_liabilities": "16.00", "net_assets_liabilities": "-202397.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-202397.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2022.zip" }, { "url": "/company/NI071217/accounts/2020-12-31", "pdf_url": "/company/NI071217/accounts/2020-12-31.pdf", "made_up_date": "2020-12-31", "period_start": "2020-12-31", "period_end": "2020-12-31", "entity_name": "Belfast Drug Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "31.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "31.00", "total_assets_less_current_liabilities": "31.00", "net_assets_liabilities": "-202239.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-202239.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2021.zip" }, { "url": "/company/NI071217/accounts/2019-12-31", "pdf_url": "/company/NI071217/accounts/2019-12-31.pdf", "made_up_date": "2019-12-31", "period_start": "2019-12-31", "period_end": "2019-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "55.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "55.00", "total_assets_less_current_liabilities": "55.00", "net_assets_liabilities": "202147.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "202147.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2020.zip" }, { "url": "/company/NI071217/accounts/2018-12-31", "pdf_url": "/company/NI071217/accounts/2018-12-31.pdf", "made_up_date": "2018-12-31", "period_start": "2018-12-31", "period_end": "2018-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "2784.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2784.00", "total_assets_less_current_liabilities": "2784.00", "net_assets_liabilities": "203087.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "203087.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2019.zip" }, { "url": "/company/NI071217/accounts/2017-12-31", "pdf_url": "/company/NI071217/accounts/2017-12-31.pdf", "made_up_date": "2017-12-31", "period_start": "2017-12-31", "period_end": "2017-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "206.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2804.00", "total_assets_less_current_liabilities": "2804.00", "net_assets_liabilities": "202337.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "202337.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2018.zip" }, { "url": "/company/NI071217/accounts/2016-12-31", "pdf_url": "/company/NI071217/accounts/2016-12-31.pdf", "made_up_date": "2016-12-31", "period_start": "2016-12-31", "period_end": "2016-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "5823.00", "cash_bank_in_hand": "361.00", "current_assets": "6184.00", "creditors_due_within_one_year": "113.00", "creditors_due_after_one_year": "206950.00", "net_current_assets_liabilities": "6071.00", "total_assets_less_current_liabilities": "6071.00", "net_assets_liabilities": "-200879.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-200881.00", "shareholder_funds": "-200879.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2017.zip" }, { "url": "/company/NI071217/accounts/2015-12-31", "pdf_url": "/company/NI071217/accounts/2015-12-31.pdf", "made_up_date": "2015-12-31", "period_start": "2015-12-31", "period_end": "2015-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "11782.00", "cash_bank_in_hand": "2954.00", "current_assets": "14736.00", "creditors_due_within_one_year": "702.00", "creditors_due_after_one_year": "214214.00", "net_current_assets_liabilities": "14034.00", "total_assets_less_current_liabilities": "14034.00", "net_assets_liabilities": "-200180.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-200182.00", "shareholder_funds": "-200180.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2016.zip" }, { "url": "/company/NI071217/accounts/2014-12-31", "pdf_url": "/company/NI071217/accounts/2014-12-31.pdf", "made_up_date": "2014-12-31", "period_start": "2014-12-31", "period_end": "2014-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "23567.00", "cash_bank_in_hand": "2353.00", "current_assets": "25920.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": "224989.00", "net_current_assets_liabilities": "25920.00", "total_assets_less_current_liabilities": "25920.00", "net_assets_liabilities": "-199069.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-199071.00", "shareholder_funds": "-199069.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2015.zip" }, { "url": "/company/NI071217/accounts/2013-12-31", "pdf_url": "/company/NI071217/accounts/2013-12-31.pdf", "made_up_date": "2013-12-31", "period_start": "2013-12-31", "period_end": "2013-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2400.00", "debtors": "3336.00", "cash_bank_in_hand": "2319.00", "current_assets": "5655.00", "creditors_due_within_one_year": "0.00", "creditors_due_after_one_year": "211877.00", "net_current_assets_liabilities": "5655.00", "total_assets_less_current_liabilities": "8055.00", "net_assets_liabilities": "-203822.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-203824.00", "shareholder_funds": "-203822.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2014.zip" }, { "url": "/company/NI071217/accounts/2012-12-31", "pdf_url": "/company/NI071217/accounts/2012-12-31.pdf", "made_up_date": "2012-12-31", "period_start": "2012-12-31", "period_end": "2012-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "5600.00", "debtors": "4346.00", "cash_bank_in_hand": "3819.00", "current_assets": "8165.00", "creditors_due_within_one_year": "1659.00", "creditors_due_after_one_year": "198386.00", "net_current_assets_liabilities": "6506.00", "total_assets_less_current_liabilities": "12106.00", "net_assets_liabilities": "-186280.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-186282.00", "shareholder_funds": "-186280.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2013.zip" }, { "url": "/company/NI071217/accounts/2011-12-31", "pdf_url": "/company/NI071217/accounts/2011-12-31.pdf", "made_up_date": "2011-12-31", "period_start": "2011-12-31", "period_end": "2011-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "13532.00", "debtors": "10224.00", "cash_bank_in_hand": "4501.00", "current_assets": "19725.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "10835.00", "total_assets_less_current_liabilities": "24367.00", "net_assets_liabilities": "-136831.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-136833.00", "shareholder_funds": "-136831.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2012.zip" }, { "url": "/company/NI071217/accounts/2010-12-31", "pdf_url": "/company/NI071217/accounts/2010-12-31.pdf", "made_up_date": "2010-12-31", "period_start": "2010-12-31", "period_end": "2010-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "31665.00", "debtors": "14202.00", "cash_bank_in_hand": "3482.00", "current_assets": "24684.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "15028.00", "total_assets_less_current_liabilities": "46693.00", "net_assets_liabilities": "-78718.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-78720.00", "shareholder_funds": "-78718.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2011.zip" }, { "url": "/company/NI071217/accounts/2009-12-31", "pdf_url": "/company/NI071217/accounts/2009-12-31.pdf", "made_up_date": "2009-12-31", "period_start": "2009-12-31", "period_end": "2009-12-31", "entity_name": "Belfast Drug Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "37853.00", "debtors": "4327.00", "cash_bank_in_hand": "2244.00", "current_assets": "6571.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1890.00", "total_assets_less_current_liabilities": "35963.00", "net_assets_liabilities": "-38198.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-38200.00", "shareholder_funds": "-38198.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2010.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/NI071217/filing-history" }, "confirmation_statement": { "next_due": "2026-12-17", "last_made_up": "2025-12-03" }, "officers": [], "psc": [ { "name": "Mr William Neil Hutton", "kind": "individual-person-with-significant-control", "person_url": "/person/5243991", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "Northern Ireland", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "stream", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-28T07:40:05+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }